Bergen Brunswig Corp

Credit Agreements Filter

EX-10.B
from 10-Q ~5 pages ] Bergen Brunswig Corporation Second Amended and Restated Executive Loan Program as of February 13, 2001
12/34/56
EX-10
from 10-K ~20 pages B. the Company Has Informed the Administrative Agent That It Seeks an Amendment of the Credit Agreement as Set Forth Herein. C. the Required Lenders Are Willing to Agree to Such Amendment Pursuant to the Terms and Subject to the Conditions Set Forth Herein. D. Each Capitalized Term Used and Not Otherwise Defined Herein Shall Have the Meaning Assigned to Such Term in the Credit Agreement. Accordingly, in Consideration of the Mutual Agreements Herein Contained and Other Good and Valuable Consideration, the Sufficiency and Receipt of Which Are Hereby Acknowledged, the Parties Hereto Agree as Follows: Section 1. Amendments to the Credit Agreement. (A) the Definition of "Consolidated Cash Interest Expense" in Section 1.01 of the Credit Agreement Is Hereby Amended and Restated in Its Entirety to Read as Follows
12/34/56
EX-10.A
from 10-Q >50 pages Credit Agreement Dated as of April 20, 2000 Among Bergen Brunswig Corporation Bergen Brunswig Drug Company Pharmerica, Inc. the Other Borrowing Subsidiaries Party Hereto the Lenders Party Hereto Wachovia Bank, N.A., as Syndication Agent First Union National Bank and Fleet National Bank, as Co-Documentation Agents Cit Financial Group, as Collateral Agent and the Chase Manhattan Bank, as Administrative Agent and Collateral Agent
12/34/56
EX-10
from 10-K/A ~10 pages First Amendment to Credit Agreement
12/34/56
EX-10
from 10-K/A ~10 pages Fifth and Sixth Amended and Restated Credit Agmt
12/34/56
EX-10.F
from 10-Q >50 pages Credit Agreement Dated as of April 23, 1999
12/34/56
EX-10.E
from 10-Q >50 pages Amended and Restated Credit Agreement
12/34/56
EX-10.H
from 10-K ~5 pages Amended and Restated Executive Loan Program
12/34/56